IDA affects greater than one in 10 Australian pregnant women and has been associated with a range of adverse maternal and infant health outcomes.3 Despite its high prevalence, there has been a significant lack of research pertaining to its optimal identification and subsequent management. This was highlighted in a recent editorial by Seeho and Morris,4 who expressed a number of clinical practice concerns including routine iron supplementation in pregnancy, increased utilisation of ferritin to screen all women for iron deficiency, and the rapidly increasing utilisation of intravenous iron.
|Number of pages||2|
|Journal||Australian and New Zealand Journal of Obstetrics and Gynaecology|
|Publication status||Published - 10 Dec 2018|
- iron‐deficiency anaemia (IDA)
- iron supplementation